Correlations (Spearman’s rank test) between the monoamine metabolites and PCL-R scores
| Pooled samples | ||||
|---|---|---|---|---|
| New sample (n=28) | All subjects ≤45 years (n=47) | All subjects without medication (n=25) | All subjects without axis I diagnosis (n=21) | |
| HVA | ||||
| PCL-R: total score | 0.32 (p=0.092) | 0.36 (p=0.014) | 0.51 (p=0.010) | 0.42 (p=0.056) |
| Factor 1 | 0.02 (p=0.93) | 0.15 (p=0.33) | 0.20 (p=0.35) | 0.28 (p=0.22) |
| Factor 2 | 0.39 (p=0.038) | 0.50 (p<0.001) | 0.66 (p<0.001) | 0.59 (p=0.005) |
| New factor 1 | 0.33 (p=0.081) | 0.26 (p=0.075) | 0.25 (p=0.22) | 0.18 (p=0.44) |
| New factor 2 | −0.03 (p=0.89) | 0.22 (p=0.15) | 0.40 (p=0.049) | 0.33 (p=0.15) |
| New factor 3 | 0.33 (p=0.086) | 0.35 (p=0.016) | 0.40 (p=0.047) | 0.42 (p=0.055) |
| 5-HIAA | ||||
| PCL-R: total score | 0.02 (p=0.92) | 0.08 (p=0.60) | 0.20 (p=0.35) | 0.06 (p=0.80) |
| Factor 1 | −0.17 (p=0.40) | −0.07 (p=0.66) | −0.07 (p=0.73) | −0.04 (p=0.87) |
| Factor 2 | 0.07 (p=0.72) | 0.22 (p=0.14) | 0.33 (p=0.10) | 0.26 (p=0.26) |
| New factor 1 | 0.17 (p=0.40) | 0.07 (p=0.63) | 0.03 (p=0.88) | −0.13 (p=0.56) |
| New factor 2 | −0.22 (p=0.27) | −0.03 (p=0.86) | 0.15 (p=0.48) | 0.11 (p=0.65) |
| New factor 3 | −0.01 (p=0.98) | 0.09 (p=0.54) | 0.11 (p=0.61) | 0.07 (p=0.77) |
| MHPG | ||||
| PCL-R: total score | 0.30 (p=0.136) | 0.38 (p=0.009) | 0.45 (p=0.023) | 0.55 (p=0.010) |
| Factor 1 | 0.13 (p=0.52) | 0.22 (p=0.14) | 0.27 (p=0.20) | 0.41 (p=0.065) |
| Factor 2 | 0.26 (p=0.18) | 0.46 (p<0.001) | 0.51 (p=0.010) | 0.60 (p=0.004) |
| New factor 1 | 0.43 (p=0.023) | 0.32 (p=0.027) | 0.35 (p=0.08) | 0.28 (p=0.21) |
| New factor 2 | 0.10 (p=0.63) | 0.28 (p=0.059) | 0.39 (p=0.056) | 0.37 (p=0.10) |
| New factor 3 | 0.45 (p=0.017) | 0.47 (p<0.001) | 0.42 (p=0.037) | 0.52 (p=0.015) |
| HVA:5-HIAA | ||||
| PCL-R: total score | 0.50 (p=0.007) | 0.50 (p<0.001) | 0.67 (p<0.001) | 0.59 (p=0.005) |
| Factor 1 | 0.28 (p=0.16) | 0.35 (p=0.016) | 0.39 (p=0.052) | 0.51 (p=0.018) |
| Factor 2 | 0.53 (p=0.004) | 0.49 (p<0.001) | 0.71 (p<0.001) | 0.58 (p=0.006) |
| New factor 1 | 0.40 (p=0.037) | 0.40 (p=0.005) | 0.36 (p=0.081) | 0.45 (p=0.039) |
| New factor 2 | 0.26 (p=0.18) | 0.40 (p=0.006) | 0.51 (p=0.010) | 0.45 (p=0.043) |
| New factor 3 | 0.49 (p=0.008) | 0.42 (p=0.003) | 0.55 (p=0.004) | 0.53 (p=0.014) |
| HVA:MHPG | ||||
| PCL-R: total score | 0.11 (p=0.57) | 0.50 (p<0.001) | 0.23 (p=0.28) | −0.01 (p=0.98) |
| Factor 1 | −0.07 (p=0.74) | 0.35 (p=0.016) | 0.03 (p=0.87) | −0.11 (p=0.65) |
| Factor 2 | 0.23 (p=0.23) | 0.49 (p<0.001) | 0.39 (p=0.055) | 0.22 (p=0.35) |
| New factor 1 | 0.13 (p=0.53) | 0.40 (p=0.005) | 0.05 (p=0.80) | −0.11 (p=0.63) |
| New factor 2 | −0.11 (p=0.58) | 0.40 (p=0.006) | 0.17 (p=0.43) | −0.001 (p=0.98) |
| New factor 3 | 0.05 (p=0.80) | 0.42 (p=0.003) | 0.15 (p=0.48) | 0.07 (p=0.77) |
| 5-HIAA:MHPG | ||||
| PCL-R: total score | −0.20 (p=0.31) | −0.16 (p=0.29) | −0.07 (p=0.74) | −0.28 (p=0.22) |
| Factor 1 | −0.23 (p=0.25) | −0.19 (p=0.20) | −0.18 (p=0.39) | −0.35 (p=0.12) |
| Factor 2 | −0.07 (p=0.73) | −0.03 (p=0.84) | 0.08 (p=0.71) | −0.08 (p=0.75) |
| New factor 1 | −0.11 (p=0.58) | −0.14 (p=0.35) | −0.11 (p=0.59) | −0.35 (p=0.12) |
| New factor 2 | −0.28 (p=0.15) | −0.18 (p=0.24) | −0.09 (p=0.67) | −0.19 (p=0.41) |
| New factor 3 | −0.28 (p=0.16) | −0.20 (p=0.18) | −0.11 (p=0.60) | −0.19 (p=0.42) |